Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 06.03.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | nge Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Off |
Stammdaten
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
Unternehmen & Branche
| Name | Vivani Medical, Inc. |
|---|---|
| Ticker | VANI |
| CIK | 0001266806 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3845 · Electromedical & Electrotherapeutic Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 77,7 Mio. USD |
| Beta | 3,37 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -26,609,000 | -0.43 | 39,393,000 | 15,730,000 | |
| 2025-09-30 | 10-Q | -6,530,000 | -0.11 | 25,046,000 | 1,309,000 | |
| 2025-06-30 | 10-Q | -7,144,000 | -0.12 | 28,905,000 | 4,910,000 | |
| 2025-03-31 | 10-Q | -6,302,000 | -0.11 | 35,452,000 | 11,624,000 | |
| 2024-12-31 | 10-K | -23,486,000 | -0.43 | 41,561,000 | 17,610,000 | |
| 2024-09-30 | 10-Q | -6,041,000 | -0.11 | 42,896,000 | 18,332,000 | |
| 2024-06-30 | 10-Q | -5,356,000 | -0.10 | 48,224,000 | 23,824,000 | |
| 2024-03-31 | 10-Q | -6,039,000 | -0.12 | 53,788,000 | 28,710,000 | |
| 2023-12-31 | 10-K | -25,652,000 | -0.50 | 45,797,000 | 20,761,000 | |
| 2023-09-30 | 10-Q | -6,782,000 | -0.13 | 53,319,000 | 26,207,000 | |
| 2023-06-30 | 10-Q | -6,526,000 | -0.13 | 59,607,000 | 32,394,000 | |
| 2023-03-31 | 10-Q | -6,318,000 | 44,580,000 | 38,368,000 | ||
| 2022-12-31 | 10-K | -13,889,000 | 51,130,000 | 44,308,000 | ||
| 2022-09-30 | 10-Q | 1,423,000 | 0.04 | 57,022,000 | 51,360,000 | |
| 2022-06-30 | 10-Q | -4,104,000 | 65,649,000 | -4,816,000 | ||
| 2022-03-31 | 10-Q | -3,924,000 | 68,538,000 | -1,118,000 | ||
| 2021-12-31 | 10-K | -1,283,000 | 5,453,000 | 2,465,000 | ||
| 2021-09-30 | 10-K | -2,501,000 | ||||
| 2021-09-30 | 10-Q | -3,491,000 | -0.10 | 73,630,000 | 1,433,000 | |
| 2021-06-30 | 10-K | -2,294,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-15 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 1,587,301 | 1.26 | 1,999,999.26 | +174,7% | |
| 2026-03-15 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 1,310,680 | 1.03 | 1,350,000.40 | +117,9% | |
| 2026-03-15 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 264,551 | 1.26 | 333,334.26 | +29,1% | |
| 2026-02-15 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 1,601,941 | 1.03 | 1,649,999.23 | +144,1% | |
| 2026-02-15 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 264,551 | 1.26 | 333,334.26 | +29,1% | |
| 2026-01-27 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 1,351,351 | 1.48 | 1,999,999.48 | +174,7% | |
| 2026-01-15 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 264,551 | 1.26 | 333,334.26 | +29,1% | |
| 2026-01-15 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 1,473,214 | 1.12 | 1,649,999.68 | +144,1% | |
| 2025-12-29 | Mendelsohn Aaron | Director | Open Market Purchase | 20,000 | 1.23 | 24,600.00 | +2,1% | |
| 2025-12-15 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 264,551 | 1.26 | 333,334.26 | +29,1% | |
| 2025-12-15 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 1,473,214 | 1.12 | 1,649,999.68 | +144,1% | |
| 2025-11-15 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 1,473,214 | 1.12 | 1,649,999.68 | +144,1% | |
| 2025-11-15 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 264,550 | 1.26 | 333,333.00 | +29,1% | |
| 2025-10-27 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 3,703,703 | 1.62 | 5,999,998.86 | +524,2% | |
| 2025-10-15 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 264,550 | 1.26 | 333,333.00 | +29,1% | |
| 2025-10-15 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 1,473,214 | 1.12 | 1,649,999.68 | +144,1% | |
| 2025-09-15 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 595,238 | 1.26 | 749,999.88 | +65,5% | |
| 2025-09-15 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 1,473,215 | 1.12 | 1,650,000.80 | +144,2% | |
| 2025-05-16 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 2,405 | 1.01 | 2,429.05 | +0,2% | |
| 2025-05-15 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 6,836 | 1.01 | 6,904.36 | +0,6% | |
| 2025-05-14 | Williams Gregg | Director, 10% Owner | Open Market Purchase | 3,499 | 1.01 | 3,533.99 | +0,3% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.